[1]王娜,李娟,李霞,等.肝硬化患者肝性脑病发生风险的回顾性研究[J].第三军医大学学报,2019,41(09):885-890.
 WANG Na,LI Juan,LI Xia,et al.Risk factors for hepatic encephalopathy in patients with liver cirrhosis: a retrospective study[J].J Third Mil Med Univ,2019,41(09):885-890.
点击复制

肝硬化患者肝性脑病发生风险的回顾性研究(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第09期
页码:
885-890
栏目:
临床医学
出版日期:
2019-05-15

文章信息/Info

Title:
Risk factors for hepatic encephalopathy in patients with liver cirrhosis: a retrospective study
作者:
王娜李娟李霞梁露文王小梅
重庆医科大学附属第二医院:肝胆外科,消化内科,感染病科
Author(s):
WANG Na LI Juan LI Xia LIANG Luwen WANG Xiaomei

Department of Hepatobiliary Surgery, Department of Gastroenterology, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China

关键词:
肝硬化肝性脑病危险因素
Keywords:
cirrhosis hepatic encephalopathy risk factor
分类号:
R181.23; R575.2; R747.9
文献标志码:
A
摘要:

目的探讨肝硬化患者发生肝性脑病的危险因素。方法选取本院2016年6月至2018年6月确诊为肝性脑病的188例肝硬化患者作为病例组,且以1∶1的比例采用随机数字表抽取同期188例肝硬化无肝性脑病患者作为对照组,分析两组肝硬化患者发生肝性脑病的危险因素。结果单因素分析发现两组病因、肝性脑病病史、肝衰竭、高蛋白饮食、腹膜炎、败/脓毒血症、碱中毒、低氯血症、低钠血症、总胆红素(TBil)、直接胆红素(DBil)、国际化标准比值(INR)、终末期肝病模型(model for end stage liver disease,MELD)评分等比较,差异具有统计学意义(P<0.05)。多因素分析发现肝性脑病病史、高蛋白饮食、碱中毒、MELD评分是肝硬化患者发生肝性脑病的独立危险因素(P<0.05),前白蛋白是其保护性因素(P<0.05)。结论肝功能严重损害、肝性脑病病史、高蛋白饮食及碱中毒等危险因素可增加肝硬化患者肝性脑病发生风险,应及时进行评估与管理。

Abstract:

ObjectiveTo explore the risk factors associated with hepatic encephalopathy in patients with cirrhosis. MethodsA total of 188 cirrhotic patients diagnosed with hepatic encephalopathy admitted in our hospital during June 2016 and June 2018 were enrolled and assigned into case group, another 188 cirrhotic patients without hepatic encephalopathy were subjected at a ratio of 1∶1 and assigned into the control group. The risk factors for hepatic encephalopathy were analyzed based on the clinical data of the 2 groups of patients. ResultsUnivariate analysis found that there were significant differences among cause of disease, history of hepatic encephalopathy, liver failure, high protein diet, peritonitis, sepsis, alkalosis, hypochloremia, hyponatremia, total bilirubin, direct bilirubin, international normalized ratio, and model for end stage liver disease (MELD) score (P<0.05). And multivariate analysis, alkalosis indicated that history of hepatic encephalopathy, high protein diet, alkalosis, and MELD score were independent risk factors for the  hepatic encephalopathy, but prealbumin was a protective factor (P<0.05). ConclusionSerious liver damage, history of hepatic encephalopathy, high protein diet, and alkalosis can increase the risk of hepatic encephalopathy in cirrhotic patients, and they should be evaluated and managed timely.

参考文献/References:

[1]PATIDAR K R, THACKER L R, WADE J B,et al. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization[J]. Am J Gastroenterol, 2014, 109(11): 1757-1763. DOI:10.1038/ajg.2014.264. 
[2]BAJAJ J S, WADE J B, GIBSON D P,et al. The multidimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers[J]. Am J Gastroenterol, 2011, 106(9): 1646-1653. DOI:10.1038/ajg.2011.157. 
[3]樊慧丽, 朱迎, 董丽. 专科品质指标对失代偿期乙肝肝硬化患者护理品质的影响[J]. 齐鲁护理杂志, 2018,24(13):51-53. DOI:10.3969/j.issn.10067256.2018.13.017.
〖DW〗FAN H L, ZHU Y, DONG L. Effect of specialist quality indicators on nursing quality of decompensated patients with hepatitis B cirrhosis[J]. J Qilu Nursing, 2018, 24(13):51-53. DOI:10.3969/j.issn.10067256.2018.13.017. 
[4]黄慧懿, 钱湘云, 陈璇, 等. 赋能教育理念在乙型肝炎肝硬化失代偿患者健康教育中的应用[J]. 中华现代护理杂志, 2018,24(29):3527-3531. DOI:10.3760/cma.j.issn.16742907.2018.29.012.
HUANG H Y, QIAN X Y, CHEN X, et al. Application of empowerment education concept in the health education for decompensated patients with hepatitis B cirrhosis[J]. Chin J Mod Nurs, 2018,24(29):3527-3531. DOI:10.3760/cma.j.issn.16742907.2018.29.012.
[5]许芳, 吴海珍. 个体化疾病管理干预对肝硬化失代偿期患者服药信念和依从性的影响[J]. 中华现代护理杂志, 2018,24(12):1457-1460. DOI:10.3760/cma.j.issn.16742907.2018.12.024.
XU F, WU H Z. Effect of individualized disease management intervention on the medication beliefs and compliance among patients with decompensated cirrhosis[J]. Chin J Mod Nurs, 2018,24(12):1457-1460. DOI:10.3760/cma.j.issn.16742907.2018.12.024.
[6]中华医学会肝病学分会,徐小元,段钟平. 肝硬化肝性脑病诊疗指南[J]. 中华肝脏病杂志, 2018,26(10):721-736. DOI:10.3760/cma.j.issn.10073418.2018.10.001.
Chinese Society of Hepatology of Chinese Medical Association,XU X P,DUAN Z P. Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis[J]. Chin J Hepatol, 2018,26(10):721-736. DOI:10.3760/cma.j.issn. 10073418.2018.10.001.
[7]PANTHAM G, POST A, VENKAT D, et al. A new look at precipitants of overt hepatic encephalopathy in cirrhosis[J]. Dig Dis Sci, 2017,62(8):2166-2173. DOI:10.1007/s106200174630y.
[8]陈新, 李慧, 孙艳辉. 肝硬化患者肝性脑病发生的影响因素分析[J]. 胃肠病学和肝病学杂志, 2015,24(11):1327-1330. DOI:10.3969/j.issn.10065709.2015.11.013.
CHEN X, LI H, SUN Y H. Influence factors of the occurrence of hepatic encephalopathy in patients with liver cirrhosis[J]. Chin J Gastroenterol Hepatol, 2015,24(11):1327-1330. DOI:10.3969/j.issn.10065709.2015.11.013.
[9]慢性乙型肝炎防治指南(2015更新版)[J]. 中华肝脏病杂志, 2015,23(12):888-905.DOI:10.3760/cma.j.issn.10073418.2015.12.002.
The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J]. Chin J Hepatol, 2015, 23(12):888-905. DOI:10.3760/cma.j.issn.10073418. 2015.12.002.
[10]中华医学会消化病学分会, 中华医学会肝病学分会,北京大学人民医院肝病科. 中国肝性脑病诊治共识意见(2013年,重庆)[J]. 中华肝脏病杂志, 2013,21(9):641-651. DOI:10.3760/cma.j.issn.10073418.2013.09.001.〖JP〗
Chinese Society of Gastroenterology, Chinese Society of Hepatology, Department of hepatiolgy of People’s Hospital of Peking University. Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013)[J]. Chin J Hepatol, 2013,21(9):641-651. DOI:10.3760/cma.j.issn.10073418. 2013.09.001.
[11]肝衰竭诊治指南(2012年版)[J]. 中华肝脏病杂志, 2013,21(3):177-183.DOI:10.3760/cma.j.issn.10073418.2013.03.006.
Diagnostic and treatment guidelines for liver failure (2012 version)[J]. Chin J Hepatol, 2013,21(3):177-183. DOI:10.3760/cma.j.issn.10073418.2013.03.006.
[12]REINTAM BLASER A, MALBRAIN M L, STARKOPF J, et al. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM working group on abdominal problems[J]. Intens Care Med, 2012, 38(3): 384-394. DOI:10.1007/s001340112459y. 
[13]翟永贞, 岳阳阳, 丁德平, 等. 血清前白蛋白联合终末期肝病模型评分评估失代偿期肝硬化患者预后的临床价值[J]. 中华肝脏病杂志, 2017, 25(7): 533-535. DOI:10.3760/cma.j.issn.10073418.2017.07.012.
ZHAI Y Z, YUE Y Y, DING D P, et al. The value of serum prealbumin combined with MELD score in predicting the prognosis of patients with decompensated cirrhosis[J]. Chin J Hepatol, 2017, 25(7): 533-535. DOI:10.3760/cma.j.issn.10073418.2017.07.012. 
[14]SAAB S. Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy[J]. Int J Gen Med, 2015, 8: 165-173. DOI:10.2147/IJGM.S81878. 
[15]BALE A, PAI C G, SHETTY S, et al. Prevalence of and factors associated with minimal hepatic encephalopathy in patients with cirrhosis of liver[J]. J Clin Exp Hepatol, 2018, 8(2): 156-161. DOI:10.1016/j.jceh.2017.06.005.〖JP〗
[16]侯玉丽, 高梦丹, 郭鸿雁, 等. 白蛋白胆红素指数与血氨联合检测对肝硬化并发肝性脑病的诊断价值评估[J]. 中华医学杂志, 2018, 98(2):127-131. DOI: 10.3760/cma.j.issn.03762491.2018.02.011.
HOU Y L, GAO M D, GUO H Y, et al. Diagnostic value of albuminbilirubin grade combined with serum ammonia in cirrhosis with hepatic encephalopathy[J]. Natl Med J China, 2018, 98(2):127-131. DOI:10.3760/cma.j.issn.03762491.2018.02.011.
[17]CHANEY A, WERNER K T, KIPPLE T. Primary care management of hepatic encephalopathy: A common cirrhosis complication[J].  J Nurs Prac, 2015, 11(3): 300-306. DOI:10.1016/j.nurpra.2014.11.005. 
[18]YOSHIMURA E, ICHIKAWA T, MIYAAKI H, et al. Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosisrelated symptoms and a history of overt hepatic encephalopathy[J]. Biomed Rep, 2016,5(2):193-198. DOI:10.3892/br.2016.702.
[19]RIGGIO O, AMODIO P, FARCOMENI A, et al. A model for predicting development of overt hepatic encephalopathy in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2015,13(7):1346-1352. DOI:10.1016/j.cgh.2014.12.025.
[20]LUO L, FU S Y , ZHANG Y Z, et al. Early diet intervention to reduce the incidence of hepatic encephalopathy in cirrhosis patients: postTransjugular Intrahepatic Portosystemic Shunt (TIPS) findings[J]. Asia Pac J Clin Nutr, 2016, 25(3):497-503. DOI:10.6133/apjcn.092015.14.
[21]李倩倩, 牛小霞, 徐碧海, 等. 肝硬化失代偿期患者主要照顾者对延续性护理需求的质性研究[J]. 解放军护理杂志, 2018,35(1):25-28. DOI:10.3969/j.issn.10089993.2018.01.005.LI Q Q, NIU X X, XU B H, et al. The qualitative study of continuity care needs of the family caregivers of the patients with decompensated live cirrhosis[J]. Nurs J Chin PLA, 2018,35(1):25-28. DOI:10.3969/j.issn.10089993.2018.01.005.
[22]MEENA R K, SUNDARMURTHY G, KARTHIK P, et al. Constipation and upper gastrointestinal bleed: Leading precipitating factors of hepatic encephalopathy in Indian cirrhotic patients[J]. Indian J Med Special, 2018, 9(4): 192-194. DOI:10.1016/j.injms.2018.06.002.

相似文献/References:

[1]王海英,吕宪民,曹亦宾,等.急性重症脑卒中并肝性脑病误诊2例[J].第三军医大学学报,2010,32(07):703.
[2]卿轶,董志.当归多糖对大鼠肝性脑病的预防作用[J].第三军医大学学报,2008,30(23):2187.
 QING Yi,DONG Zhi.Angelica sinensis polysaccharides prevents rat from hepatic encephalopathy[J].J Third Mil Med Univ,2008,30(09):2187.
[3]胡扬腾,于世远,张殿玉,等.33例肝性脑病酸碱失衡的分析[J].第三军医大学学报,1985,07(03):0.[doi:10.16016/j.1000-5404.1985.03.011 ]
 Hu Yangteng,Yu Shiyuan,Zhang Dianyu.[J].J Third Mil Med Univ,1985,07(09):0.[doi:10.16016/j.1000-5404.1985.03.011 ]
[4]何振平,刘永雄.闭塞分流口治愈预防性脾脏分流术后肝性脑病一例[J].第三军医大学学报,1982,04(03):0.[doi:10.16016/j.1000-5404.1982.03.016 ]
[5]王威巍,张宇,尤楠,等.粪便细菌移植对肝性脑病大鼠肝功能及血氨的影响[J].第三军医大学学报,2017,39(13):1321.
 WANG Weiwei,ZHANG Yu,YOU Nan,et al.Effects of fecal microbiota transplantation on liver function and blood ammonia in hepatic encephalopathy rats[J].J Third Mil Med Univ,2017,39(09):1321.
[6]陈静,肖天利,龙庆林,等.经颈静脉不同门静脉分支穿刺分流对肝硬化患者血氨水平的影响[J].第三军医大学学报,2018,40(07):610.
 CHEN Jing,XIAO Tianli,LONG Qinglin,et al.Effect of transjugular intrahepatic portosystemic shunt placement in different branches of portal vein on plasma ammonia level in cirrhotic patients[J].J Third Mil Med Univ,2018,40(09):610.
[7]胡小鹏,高建.国际标准化比值和终末期肝病模型评分对并发肝性脑病的肝硬化患者短期预后的预测价值[J].第三军医大学学报,2019,41(14):1374.
 HU Xiaopeng,GAO Jian.International normalized ratio and model for end-stage liver disease score for predicting short-term prognosis of cirrhotic patients with hepatic encephalopathy[J].J Third Mil Med Univ,2019,41(09):1374.

更新日期/Last Update: 2019-05-08